ArticleCancer immunology, immunotherapy : CII2022

Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.

Yanze Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.